Lauren Merendino

Insider Reports History

Entity
Individual
Location
C/O Myovant Sciences Inc., 2000 Sierra Point Parkway, 9 Th Floor, Brisbane, CA
Signature
/s/ Lauren Merendino
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Lauren Merendino:

Stock Role Class Num Shares Value Price $ Report Date Ownership
ESSA Pharma Inc. Director Options 25K Mar 25, 2024 Direct
Myovant Sciences Ltd. Chief Commercial Officer Common Shares 0 $27.00 Mar 10, 2023 Direct
Myovant Sciences Ltd. Chief Commercial Officer Performance Stock Unit 0 Mar 10, 2023 Direct
Myovant Sciences Ltd. Chief Commercial Officer Stock Options (Right to Buy) 0 Mar 10, 2023 Direct

Insider Reports Filed by Lauren Merendino

Symbol Company Period Transactions Value $ Form Type Date Filed Role
EPIX ESSA Pharma Inc. Mar 25, 2024 1 $0 4 Mar 28, 2024 Director
EPIX ESSA Pharma Inc. Jun 6, 2023 0 $0 3 Jun 6, 2023 Director
MYOV Myovant Sciences Ltd. Mar 10, 2023 4 $0 4 Mar 10, 2023 Chief Commercial Officer
MYOV Myovant Sciences Ltd. Jan 18, 2023 1 -$54K 4 Jan 20, 2023 Chief Commercial Officer
MYOV Myovant Sciences Ltd. Oct 18, 2022 1 -$42.9K 4 Oct 20, 2022 Chief Commercial Officer
MYOV Myovant Sciences Ltd. Jul 18, 2022 1 -$21.9K 4 Jul 20, 2022 Chief Commercial Officer
MYOV Myovant Sciences Ltd. Apr 19, 2022 1 -$73.7K 4 Apr 21, 2022 Chief Commercial Officer
MYOV Myovant Sciences Ltd. Apr 15, 2022 1 $0 4 Apr 19, 2022 Chief Commercial Officer